Targeted Rapid Endotoxin Adsorption (TREA) Therapy: Advancing the Standard of Care for Endotoxic Septic Shock (ESS)

Join us for an engaging dinner meeting focused on one of the most promising emerging therapies in septic shock care. This session will explore Targeted Rapid Endotoxin Adsorption (TREA) Therapy, an innovative extracorporeal blood purification strategy designed to rapidly remove circulating endotoxin—the key driver of inflammation, vasoplegia, and multi-organ failure in endotoxic septic shock (ESS).

Through an evidence-based discussion, participants will review the pathophysiology of endotoxin-mediated shock, current limitations of standard sepsis management, and how TREA therapy may help close critical gaps in care by addressing the underlying biologic trigger rather than only supporting failing organs. Clinical trial data, patient selection criteria, timing of therapy, and practical implementation in the ICU will be highlighted.

This dinner meeting is open to all members and colleagues involved in the care of critically ill patients, including physicians, advanced practice providers, nurses, and dialysis specialists. Whether you work at the bedside, in education, or in quality and outcomes, this is an opportunity to stay at the forefront of evolving sepsis management.

Come for the food, stay for the learning—and be part of a forward-thinking conversation about how we can improve survival and recovery for patients with endotoxic septic shock.